idiopathic pulmonary fibrosis

Utilisation of whole slide image analysis to quantify lesion formation, collagen content and cell density within histologically stained fibrotic lung tissue
Lorcan Sherry, Mark Anderson, Alison Bigley, Kieran McGregor, Stuart Naylor, Claudio Petterino, Mary McElroy

European Respiratory Journal Sep 2016, 48 (suppl 60) PA890; DOI: 10.1183/13993003.congress-2016.PA890
Neoplasia in patients with ILD; shortened survival
Nesrin Mogulkoc, Aysu Sinem Koc, Imren Nesil, Pervin Korkmaz Ekren, Ali Veral, Yasemin Kabasakal, Ahmet Uysal, Feza Bacakoglu, Selen Bayraktaroglu

European Respiratory Journal Sep 2016, 48 (suppl 60) PA807; DOI: 10.1183/13993003.congress-2016.PA807
Anti-fibrotic efficacy of nintedanib on pulmonary fibrosis via suppression of fibrocyte activity
Shun Morizumi, Seidai Sato, Shuichi Abe, Hiroyasu Okazaki, Yanjuan Chen, Hisatsugu Goto, Yoshinori Aono, Hirohisa Ogawa, Masaki Hanibuchi, Hisanori Uehara, Yasuhiko Nishioka

European Respiratory Journal Sep 2016, 48 (suppl 60) PA778; DOI: 10.1183/13993003.congress-2016.PA778
Study of factors affecting mortality in ILD cases over 2 years
Sameer Arbat, Amita Athavale, Jairaj Nair, Sneha Tirpude, Anshu Punjabi

European Respiratory Journal Sep 2016, 48 (suppl 60) PA806; DOI: 10.1183/13993003.congress-2016.PA806
Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells
Argyris Tzouvelekis, Guoying Yu, Jose Herazo-Maya, Rong Wang, Joao Pedro S. Werneck de Castro, Giuseppe DeIuliis, Farida Ahangari, Tony Woolard, Rafael Arrojo e Drigo, Robert Homer, Anup Srivastava, Erica Herzog, Patty Lee, Antonio Bianco, Naftali Kaminski

European Respiratory Journal Sep 2016, 48 (suppl 60) PA780; DOI: 10.1183/13993003.congress-2016.PA780
Effects of NecroX compounds on bleomycin-induced pulmonary fibrosis
Yong Chul Lee, So Ri Kim, Kyung Bae Lee, Hae Jin Park, Soon Ha Kim

European Respiratory Journal Sep 2016, 48 (suppl 60) PA783; DOI: 10.1183/13993003.congress-2016.PA783
Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
John Hutchinson, Tricia McKeever, Andrew Fogarty, Vidya Navaratnam, Richard Hubbard

European Respiratory Journal Sep 2016, 48 (suppl 60) PA802; DOI: 10.1183/13993003.congress-2016.PA802
Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study
Fabián Matias Caro, Martín Eduardo Fernández, María Laura Alberti, Francisco Paulin

European Respiratory Journal Sep 2016, 48 (suppl 60) PA791; DOI: 10.1183/13993003.congress-2016.PA791
The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF)
Marlies S. Wijsenbeek-Lourens, Merel L. Kimman, Adrienne Rotteveel, Xana van Jaarsveld, Stephanie S. Weinreich, Remy Mostard, Carmen D. Dirksen

European Respiratory Journal Sep 2016, 48 (suppl 60) PA793; DOI: 10.1183/13993003.congress-2016.PA793
Do typical and atypical HRCT patterns make difference in prognosis of patients with IPF?
Martina Vašáková, Martina Sterclova, Vladimir Bartos, Martina Doubkova, Martina Plackova, Monika Zurkova, Vladimira Lostakova, Ladislav Lacina, Vladimir Rihak, Frantisek Petrik, Pavlina Lisa, Radka Bittenglova, Richard Tyl, Gustav Ondrejka, Hana Suldova, Jaroslav Lnenicka, Jana Psikalova, Tomas Snizek, Jiri Homolka, Renata Kralova, Jan Kervitzer, Michal Svoboda, Jana Strenkova, Athol Wells

European Respiratory Journal Sep 2016, 48 (suppl 60) PA795; DOI: 10.1183/13993003.congress-2016.PA795

Main menu

User menu

Search

idiopathic pulmonary fibrosis

Pages